| Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo M Ishii, J Kikuta, Y Shimazu, M Meier-Schellersheim, RN Germain Journal of Experimental Medicine 207 (13), 2793-2798, 2010 | 279 | 2010 |
| Graft-versus-host disease amelioration by human bone marrow mesenchymal stromal/stem cell-derived extracellular vesicles is associated with peripheral preservation of naive T … S Fujii, Y Miura, A Fujishiro, T Shindo, Y Shimazu, H Hirai, H Tahara, ... Stem cells 36 (3), 434-445, 2018 | 208 | 2018 |
| Central nervous system event in patients with diffuse large B‐cell lymphoma in the rituximab era N Tomita, M Yokoyama, W Yamamoto, R Watanabe, Y Shimazu, Y Masaki, ... Cancer science 103 (2), 245-251, 2012 | 108 | 2012 |
| Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single-center experience Y Shimazu, K Notohara, Y Ueda International journal of hematology 89, 577-583, 2009 | 104 | 2009 |
| A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancers N Sugino, M Kawahara, G Tatsumi, A Kanai, H Matsui, R Yamamoto, ... Leukemia 31 (11), 2303-2314, 2017 | 74 | 2017 |
| Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation N Doki, M Suyama, S Sasajima, J Ota, A Igarashi, I Mimura, H Morita, ... Annals of Hematology 96, 1517-1523, 2017 | 65 | 2017 |
| Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia Y Shimazu, Y Shimazu, M Hishizawa, M Hamaguchi, Y Nagai, N Sugino, ... Cancer immunology research 4 (2), 136-145, 2016 | 43 | 2016 |
| Human herpesvirus‐6 encephalitis during hematopoietic stem cell transplantation leads to poor prognosis Y Shimazu, T Kondo, T Ishikawa, K Yamashita, A Takaori‐Kondo Transplant Infectious Disease 15 (2), 195-201, 2013 | 36 | 2013 |
| The role of sphingosine 1-phosphate in migration of osteoclast precursors; an application of intravital two-photon microscopy T Ishii, Y Shimazu, I Nishiyama, J Kikuta, M Ishii Molecules and cells 31, 399-403, 2011 | 32 | 2011 |
| The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis N Tomita, M Yokoyama, W Yamamoto, R Watanabe, Y Shimazu, Y Masaki, ... Leukemia & lymphoma 59 (1), 97-104, 2018 | 22 | 2018 |
| Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine Y Shimazu, S Mizuno, S Fuchida, K Suzuki, N Tsukada, A Hanagaishi, ... Cancer Science 112 (12), 5034-5045, 2021 | 20 | 2021 |
| Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma TM Kim, M Taszner, S Novelli, SG Cho, JC Villasboas, M Merli, ... Annals of Oncology 35 (11), 1039-1047, 2024 | 19 | 2024 |
| Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis T Takakuwa, R Yamamura, K Ohta, H Kaneko, K Imada, A Nakaya, ... European Journal of Haematology 106 (4), 555-562, 2021 | 13 | 2021 |
| Real-world effectiveness and safety analysis of carfilzomib–lenalidomide–dexamethasone and carfilzomib–dexamethasone in relapsed/refractory multiple myeloma: a multicenter … Y Onda, J Kanda, H Kaneko, Y Shimura, S Fuchida, A Nakaya, T Itou, ... Therapeutic Advances in Hematology 13, 20406207221104584, 2022 | 9 | 2022 |
| Retrospective multi-center study of adolescent and young adult (AYA) multiple Myeloma in Kansai Myeloma Forum registry A Nakaya, T Kohara, H Shibayama, Y Onda, J Kanda, H Kaneko, K Imada, ... International Journal of Hematology 112, 435-438, 2020 | 7 | 2020 |
| Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin Y Shimazu, J Kanda, S Kosugi, T Ito, H Kaneko, K Imada, Y Shimura, ... scientific reports 13 (1), 5159, 2023 | 6 | 2023 |
| The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation Y Shimazu, M Murata, T Kondo, Y Minami, T Tachibana, N Doki, N Uchida, ... Hematological Oncology 40 (3), 442-456, 2022 | 6 | 2022 |
| Hyponatremia in a multiple myeloma patient treated with bortezomib. Y Shimazu, K Fujimura Hematological Oncology 35 (4), 929-930, 2016 | 5 | 2016 |
| Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma Y Okada, F Kimura, N Kurita, H Takahashi, Y Shimazu, S Mizuno, ... Cytotherapy 25 (11), 1212-1219, 2023 | 4 | 2023 |
| Efficacy of autologous stem cell transplantation for myeloma patients with suboptimal response: a multicenter retrospective analysis K Suzuki, Y Shimazu, D Minakata, T Ikeda, H Takahashi, N Tsukada, ... Transplantation and Cellular Therapy 29 (11), 688. e1-688. e13, 2023 | 4 | 2023 |
